Evening vs morning nerve testing in myasthenia gravis
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This study compares how well a nerve test works when done in the evening versus in the morning for people with myasthenia gravis. It may help doctors choose the best time to test nerve fatigue and better measure disease activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have suspected or diagnosed myasthenia gravis (eye-only or full-body).
- You can have blood tests for anti-AChR and/or anti-MUSK antibodies now or already have them.
- Your myasthenia symptoms are at least mild (not the very lowest severity group).
- You do not have breathing failure.
- You do not have severe trouble swallowing or speaking related to the illness.
- Your current medicines do not include drugs that could make nerve-to-muscle signals worse for this test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with suspected or confirmed myasthenia gravis (a condition that causes muscle weakness that gets worse with use). It uses several specialized nerve and antibody tests to make a more precise diagnosis and tracks you over time to see how well these methods work.
This study looks at how common and how severe fatigue is in people with myasthenia gravis. It aims to understand the impact of fatigue on daily life and may help improve care for patients with this condition.
This study uses wearable sensors to track symptoms of myasthenia gravis in daily life. The goal is to see if these devices can better monitor how the disease changes over time.
This study compares light exercise (like gentle walking) to moderate exercise (like brisk walking) for people with myasthenia gravis. It aims to see if one type of exercise is safer and more helpful for managing symptoms.
This study tests a smartphone-based digital tool that helps check symptoms in people with generalized myasthenia gravis (MG). It may help patients and clinicians track how the disease is doing over time using simpler, repeated assessments.
This trial tests an experimental oral medication called NMD670 for people with myasthenia gravis (MG). It aims to see if the drug is safe and if it helps improve muscle strength and daily function.
Hear when a new Myasthenia Gravis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.